Abbott Molecular Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Abbott Molecular Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6601
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abbott Molecular Inc (Abbott Molecular), formerly Vysis Inc, a subsidiary of Abbott Laboratories, is a medical diagnostics company that provides molecular testing solutions. The company offers infectious disease products, oncology products, genetics products, automation products, molecular diagnostics and assays. It provide PathVysion HER-2 DNA Probe kits, ALK break apart FISH probe kits, and UroVysion bladder cancer kits. Abbott Molecular also offers multi collect specimen collection kits, amplification reagent kits, control kits, HBV application CD-ROM, HBV calibrator and control kits, antifade solutions, CGH hybridization reagents, and FISH pretreatment reagent kits, among others. The company’s therapeutic areas include breast cancer, automation, genetics, infectious disease, and oncology. It has presence in Africa, Asia, Europe, North America, South America and others. Abbott Molecular is headquartered in Des Plaines, Illinois, the US.

Abbott Molecular Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abbott Molecular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abbott Molecular Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abbott Molecular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abbott Molecular Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Abbott Molecular Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abbott Molecular Inc, Medical Equipment, Deal Details 10
Partnerships 10
Abbott Molecular Enters into Co-Development Agreement with Biocartis 10
Idera Pharma Enters Into Co-Development Agreement With Abbott Molecular For In Vitro Companion Diagnostic Test 11
BioGenex Labs Enters Into Co-Marketing Agreement With Abbott Molecular 12
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 13
BioView Enters Into Agreement With Abbott To Develop Automated Cancer Screening System 14
Abbott Molecular Inc – Key Competitors 15
Abbott Molecular Inc – Key Employees 16
Abbott Molecular Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Abbott Molecular Inc, Medical Equipment, Key Facts 2
Abbott Molecular Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abbott Molecular Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abbott Molecular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abbott Molecular Inc, Deals By Market, 2012 to YTD 2018 8
Abbott Molecular Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abbott Molecular Enters into Co-Development Agreement with Biocartis 10
Idera Pharma Enters Into Co-Development Agreement With Abbott Molecular For In Vitro Companion Diagnostic Test 11
BioGenex Labs Enters Into Co-Marketing Agreement With Abbott Molecular 12
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 13
BioView Enters Into Agreement With Abbott To Develop Automated Cancer Screening System 14
Abbott Molecular Inc, Key Competitors 15
Abbott Molecular Inc, Key Employees 16
Abbott Molecular Inc, Other Locations 17

List of Figures
Abbott Molecular Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abbott Molecular Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Abbott Molecular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abbott Molecular Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Abbott Molecular Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Harvard Bioscience Inc (HBIO):医療機器:M&Aディール及び事業提携情報
    Summary Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets scientific instruments systems and lab consumables. The company’s product portfolio encompasses physiology, cell, molecular instruments products; electrophysiology products; and laboratory products and supplies. I …
  • Vietnam Enterprise Investments Limited (VEIL):企業の財務・戦略的SWOT分析
    Vietnam Enterprise Investments Limited (VEIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • KDDI Corporation (9433):企業の財務・戦略的SWOT分析
    KDDI Corporation (9433) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • A.F. Blakemore & Son Ltd (Foodservice):企業の戦略・SWOT・財務情報
    A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Straumann Holding AG (STMN)-医療機器分野:企業M&A・提携分析
    Summary Straumann Holding AG (Straumann) develops dental implants and devices. Straumann’s product portfolio includes dental implants, active surfaces, prosthetic components, digital solutions such as intra-oral scanning, and CADCAM, bone substitutes, and regenerative membranes. The company categori …
  • Mentor Graphics Corp:企業の戦略的SWOT分析
    Mentor Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Meridian Energy Limited:企業の戦略・SWOT・財務分析
    Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Viacom, Inc.:企業の戦略・SWOT・財務情報
    Viacom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Viacom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • PolyNovo Ltd (PNV):医療機器:M&Aディール及び事業提携情報
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd, is a medical device company that develops, manufactures and commercializes biodegradable polymers for use in medical devices. The company provides products such as biodegradable temporizing matrix and negative pressure wound therapy dressing sys …
  • HABAU Hoch- und TiefbauGmbH:企業の戦略的SWOT分析
    HABAU Hoch- und TiefbauGmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Crisil Ltd (CRISIL):企業の財務・戦略的SWOT分析
    Summary Crisil Ltd (Crisil), a subsidiary of S&P Global Inc is a financial service provider that offers risk management services. The company provides ratings, research and risk and policy advisory services. It offers services such as credit ratings, business school gradings, real estate star rating …
  • NextEra Energy Inc (NEE):企業の財務・戦略的SWOT分析
    NextEra Energy Inc (NEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Chesapeake Energy Corporation:企業の戦略・SWOT・財務情報
    Chesapeake Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Chesapeake Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • SOL SpA (SOL):企業の財務・戦略的SWOT分析
    Summary SOL SpA (SOL), a subsidiary of Gas and Technologies World BV, is engaged in research, produces and distributes industrial, pure, technical, and medicinal gases. The company’s technical gases include nitrogen, oxygen, hydrogen, carbon dioxide, argon, nitrous oxide, acetylene, medical gases, g …
  • Mecklenburg Electric Cooperative:企業の戦略的SWOT分析
    Mecklenburg Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Polski Koncern Naftowy Orlen SA (PKN):企業の財務・戦略的SWOT分析
    Polski Koncern Naftowy Orlen SA (PKN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Advanced Proteome Therapeutics Corp (APC):企業の財務・戦略的SWOT分析
    Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Sunflower Electric Power Corporation:企業の戦略的SWOT分析
    Sunflower Electric Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Insurance Corporation of Barbados Limited:企業の戦略・SWOT・財務情報
    Insurance Corporation of Barbados Limited - Strategy, SWOT and Corporate Finance Report Summary Insurance Corporation of Barbados Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Slovnaft AS (1SLN01AE):企業の財務・戦略的SWOT分析
    Slovnaft AS (1SLN01AE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆